Target intelligence / Profile preview

Escherichia coli cell surface receptor

Molecular classification
Receptor, Adhesin, Outer membrane protein, Porin, Lipopolysaccharide
01

Overview

Escherichia coli cell surface receptors represent a heterogeneous group of molecules, including proteins and lipopolysaccharides, that facilitate the bacterium's interaction with its environment and host cells (Silhavy et al., 2010). Key components include adhesins such as FimH, which is located at the tip of type 1 pili and mediates binding to mannosylated receptors on host epithelial cells, a critical step in the pathogenesis of urinary tract infections (Spaulding et al., 2017). Other significant receptors include outer membrane proteins (OMPs) like OmpA and OmpC, which serve as porins for nutrient transport and structural components, as well as receptors for bacteriophages (Koebnik et al., 2000). These surface structures are prime targets for therapeutic development; for example, small-molecule mannosides like Sibofimloc are designed to inhibit FimH-mediated adhesion, while polymyxins target the lipopolysaccharide (LPS) layer to disrupt membrane integrity (Klein et al., 2010). Additionally, the specificity of bacteriophages for particular surface receptors is being exploited in phage therapy to treat multi-drug resistant E. coli infections (Bertozzi Silva et al., 2016). Targeting these surface components offers a strategy to prevent infection or overcome antibiotic resistance by disrupting the initial stages of bacterial pathogenesis.

Other names
E. coli surface proteinsE. coli adhesinsE. coli outer membrane proteinsOMPsBacterial cell envelope receptors
02

Mechanism of action

Inhibition of bacterial adhesion to host cells, disruption of outer membrane integrity, and facilitation of bacteriophage entry into the bacterial cell.

03

Biological functions

Cell adhesionNutrient transportSignal transductionStructural integrityBacteriophage binding
04

Disease associations

InfectionUrinary tract infectionSepsisDiarrheal diseaseNeonatal meningitis
05

Safety considerations

Potential for rapid emergence of resistance via receptor mutationsOff-target effects on beneficial commensal E. coli strainsRisk of Jarisch-Herxheimer-like reactions due to endotoxin release during bacterial lysis
06

Interacting drugs

Sibofimloc

3 more in the full profile.

07

Biomarkers

FimH expression levelsLPS O-antigen serotypeOuter membrane protein profiling

Beyond the preview

Go deeper on Escherichia coli cell surface receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli cell surface receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call